These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6777812)

  • 81. [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].
    Lehmann E; Quadbeck H; Tegeler J; Fararuni M; Heinrich K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):117-29. PubMed ID: 7393998
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY; Busch DA; Fang VS
    Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M; Alvarez C; Herlin S
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetic studies of highly purified human prolactin in normal human subjects.
    Molitch ME; Raiti S; Baumann G; Belknap S; Reichlin S
    J Clin Endocrinol Metab; 1987 Aug; 65(2):299-304. PubMed ID: 3597709
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
    Koreen AR; Lieberman J; Alvir J; Chakos M; Loebel A; Cooper T; Kane J
    Am J Psychiatry; 1994 Jan; 151(1):35-9. PubMed ID: 8267132
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
    Ohura K; Nakada Y; Imai T
    J Pharm Sci; 2023 Jul; 112(7):1975-1984. PubMed ID: 37019360
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fluphenazine pharmacokinetics and therapeutic response.
    Dysken MW; Javaid JI; Chang SS; Schaffer C; Shahid A; Davis JM
    Psychopharmacology (Berl); 1981; 73(3):205-10. PubMed ID: 6787637
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
    Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
    Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The neuroleptic drug fluphenazine induces a significant UVA-mediated cytotoxic effect on three human cancer cell lines through apoptosis.
    Menilli L; García-Argáez AN; Dalla Via L; Miolo G
    Photochem Photobiol Sci; 2019 Sep; 18(9):2232-2239. PubMed ID: 30860541
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.
    Weizman A; Tyano S; Wijsenbeek H; Ben David M
    Psychopharmacology (Berl); 1984; 82(4):382-5. PubMed ID: 6427833
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Family attitudes and patient social adjustment in a longitudinal study of outpatient schizophrenics receiving low-dose neuroleptics: the family's view.
    Kreisman D; Blumenthal R; Borenstein M; Woerner M; Kane J; Rifkin A; Reardon G
    Psychiatry; 1988 Feb; 51(1):3-13. PubMed ID: 3368545
    [TBL] [Abstract][Full Text] [Related]  

  • 94. DEPOT FLUPHENAZINE ENANTHATE TREATMENT OF OUTPATIENT SCHIZOPHRENICS.
    BLACHLY PH
    J New Drugs; 1965; 5(2):114-6. PubMed ID: 14315149
    [No Abstract]   [Full Text] [Related]  

  • 95. The effect of fluphenazine on basal prolactin concentrations.
    Chalmers RJ; Bennie EH
    Psychol Med; 1978 Aug; 8(3):483-6. PubMed ID: 704714
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Seizures associated with clozapine treatment in a state hospital.
    Wilson WH; Claussen AM
    J Clin Psychiatry; 1994 May; 55(5):184-8. PubMed ID: 8071267
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Agranulocytosis: incidence and risk factors.
    Alvir JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients.
    Nathan RS; Sachar EJ; Ostrow L; Asnis GM; Halbreich U; Halpern F; Renzi NL; Slotnick V
    Psychopharmacology (Berl); 1983; 80(1):46-9. PubMed ID: 6408670
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.
    Dencker SJ; Johansson R; Malm U
    Psychopharmacology (Berl); 1988; 94(2):237-41. PubMed ID: 3127851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.